Hamad A - Search Results

1

Quantification of the growth suppression of HER2+ breast cancer colonies under the effect of trastuzumab and PD-1/PD-L1 inhibitor.

Padmanabhan R, Kheraldine H, Gupta I, Meskin N, Hamad A, Vranic S, Al Moustafa AE. Padmanabhan R, et al. Among authors: hamad a. Front Oncol. 2022 Dec 7;12:977664. doi: 10.3389/fonc.2022.977664. eCollection 2022. Front Oncol. 2022. PMID: 36568154 Free PMC article.

2

Clustering and Stochastic Simulation Optimization for Outpatient Chemotherapy Appointment Planning and Scheduling.

Hadid M, Elomri A, Padmanabhan R, Kerbache L, Jouini O, El Omri A, Nounou A, Hamad A. Hadid M, et al. Among authors: hamad a. Int J Environ Res Public Health. 2022 Nov 23;19(23):15539. doi: 10.3390/ijerph192315539. Int J Environ Res Public Health. 2022. PMID: 36497611 Free PMC article.

3

The effectiveness and safety of palbociclib and ribociclib in stage IV HR+/HER-2 negative breast cancer: a nationwide real world comparative retrospective cohort study.

Al-Ziftawi NH, Elazzazy S, Alam MF, Shafie A, Hamad A, Bbujassoum S, Mohamed Ibrahim MI. Al-Ziftawi NH, et al. Among authors: hamad a. Front Oncol. 2023 Dec 15;13:1203684. doi: 10.3389/fonc.2023.1203684. eCollection 2023. Front Oncol. 2023. PMID: 38162489 Free PMC article.

4

Effect of denosumab versus zoledronic acid on calcium levels in cancer patients with bone metastasis: A retrospective cohort study.

Nasser SM, Sahal A, Hamad A, Elazzazy S. Nasser SM, et al. Among authors: hamad a. J Oncol Pharm Pract. 2019 Dec;25(8):1846-1852. doi: 10.1177/1078155218820927. Epub 2019 Jan 7. J Oncol Pharm Pract. 2019. PMID: 31694497 Free PMC article.

5

Diagnosis and Management of Hematological Adverse Events Induced by Immune Checkpoint Inhibitors: A Systematic Review.

Omar NE, El-Fass KA, Abushouk AI, Elbaghdady N, Barakat AEM, Noreldin AE, Johar D, Yassin M, Hamad A, Elazzazy S, Dermime S. Omar NE, et al. Among authors: hamad a. Front Immunol. 2020 Oct 21;11:1354. doi: 10.3389/fimmu.2020.01354. eCollection 2020. Front Immunol. 2020. PMID: 33193289 Free PMC article.

6

Characteristics of the clinical pharmacist interventions at the National Center for Cancer Care and Research Hospital in Qatar.

Al Dali S, Al-Badriyeh D, Gulied A, Hamad A, Hail MA, Rouf PVA, El-Kassem W, Abushanab D. Al Dali S, et al. Among authors: hamad a. J Oncol Pharm Pract. 2023 Jul 11:10781552231187305. doi: 10.1177/10781552231187305. Online ahead of print. J Oncol Pharm Pract. 2023. PMID: 37431260

We sought to analyze the clinical pharmacist-documented interventions among hospitalized patients in the cancer hospital in Qatar. METHODS: A retrospective analysis of electronically reported clinical pharmacist interventions of patients admitted to cancer units at Hama …

We sought to analyze the clinical pharmacist-documented interventions among hospitalized patients in the cancer hospital in Qatar. METHODS: …

7

Perceptions and expectations of health care providers towards clinical pharmacy services at a tertiary cancer centre in Qatar.

Omar NE, Elazzazy S, Abdallah O, Nashwan AJ, Eltorki Y, Afifi HM, Kassem N, Yassin M, Hamad A. Omar NE, et al. Among authors: hamad a. J Oncol Pharm Pract. 2020 Jul;26(5):1086-1096. doi: 10.1177/1078155219882076. Epub 2019 Nov 13. J Oncol Pharm Pract. 2020. PMID: 31718469 Free PMC article.

8

Predictors of community pharmacists' readiness to manage the effective and safe use of oral anticancer medicines in a developing setting.

Dahmani S, Cerbito EF, Hamad A, Yusuff KB. Dahmani S, et al. Among authors: hamad a. J Oncol Pharm Pract. 2023 Oct;29(7):1580-1589. doi: 10.1177/10781552221141696. Epub 2022 Nov 25. J Oncol Pharm Pract. 2023. PMID: 36426549

9

Cost savings and cost avoidance with the inpatient clinical pharmacist interventions in a tertiary cancer care hospital.

Abushanab D, Gulied A, Hamad A, Abu-Tineh M, Abdul Rouf PV, Al Hail M, El-Kassem W, El Hajj MS, Al-Badriyeh D. Abushanab D, et al. Among authors: hamad a. J Oncol Pharm Pract. 2023 Dec;29(8):1935-1943. doi: 10.1177/10781552231160275. Epub 2023 Mar 22. J Oncol Pharm Pract. 2023. PMID: 36946146

10

Cost-Effectiveness and Cost-Utility of Palbociclib versus Ribociclib in Women with Stage IV Breast Cancer: A Real-World Data Evaluation.

Al-Ziftawi NH, Alam MF, Elazzazy S, Shafie AA, Hamad A, Mohamed Ibrahim MI. Al-Ziftawi NH, et al. Among authors: hamad a. Int J Environ Res Public Health. 2022 Dec 28;20(1):512. doi: 10.3390/ijerph20010512. Int J Environ Res Public Health. 2022. PMID: 36612831 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

685 results

Search Page